我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
437
17 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1895
进行中(未招募)
6
1.4%
已完成
311
71.2%
Enrolling By Invitation
1
0.2%
尚未招募
10
2.3%
招募中
18
4.1%
暂停
20
4.6%
终止
50
11.4%
Unknown
撤回
暂无批准数据
- A pilot study indicates that psilocybin significantly reduced symptoms in individuals with body dysmorphic disorder (BDD). - Brain scans revealed that psilocybin treatment increased connectivity between brain regions related to emotional processing and cognitive activity. - The improvement in BDD symptoms correlated with the strengthening of connections within brain networks, suggesting enhanced brain flexibility. - Further research with larger groups is necessary to confirm the effectiveness and long-term effects of psilocybin for treating BDD.